DexCom IncNASDAQ:DXCM

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

-- Kevin Sayer, President & Chief Operating Officer, will present an update on DexCom at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, Nevada on Thursday, May 16, 2013 10:00 a.m. (PDT). The presentation, which will occur live at the Encore Hotel, will be concurrently webcast.

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2013.

Product revenue grew to $27.8 million for the first quarter of 2013, an increase of approximately 49% from the $18.6 million in product revenue reported for the first quarter of 2012. Total first quarter 2013 revenue, which included development grant and other revenue, grew to $29.6 million, an increase of 47% from the same quarter in 2012. Product gross profit totaled $15.4 million for the three months ended March 31, 2013, compared to a product gross profit of $9.0 million for the three months ended March 31, 2012. The Company reported a net loss of $11.1 million, or $0.16 per share for the three months ended March 31, 2013, compared to a net loss of $14.1 million, or $0.21 per share for the three months ended March 31, 2012. The net loss of $11.1 million included $7.2 million in non-cash expenses, comprised primarily of share-based compensation, depreciation, and amortization.